Floatz logo

Metformin

Sleep Apnea, Obstructive

Pennington Biomedical Research CenterSmall moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Sleep Apnea, Obstructive cohort.

Asset / SponsorPhaseRating
Adalimumab
Innovaderm Research Inc.
Phase 4BB
MELATONIN
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Phase 4BB
Liraglutide
St Vincent's University Hospital, Ireland
Phase 3BB
xw003
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 3B
Mazdutide
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3B

View all 16 →

Same molecule, other indications

Metformin is also rated in:

Metabolism and Nutrition DisorderDormant
A
Indicative ·
82 / 100
View asset →
prediabetes syndromeDormant
A
Indicative ·
81 / 100
View asset →
gestational diabetesDormant
A
Indicative ·
81 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →